Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-15-021424
Filing Date
2015-04-07
Accepted
2015-04-06 19:25:21
Documents
4
Period of Report
2015-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v406700_6k.htm 6-K 23114
2 EXHIBIT 5.1 v406700_ex5-1.htm EX-5.1 8305
3 EXHIBIT 10.1 v406700_ex10-1.htm EX-10.1 220976
4 EXHIBIT 10.2 v406700_ex10-2.htm EX-10.2 104248
  Complete submission text file 0001144204-15-021424.txt   357658
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 15754690
SIC: 2834 Pharmaceutical Preparations